FeesSafety
Pluang+

S&P 500 stagnant for 5 months but valuations drop, making stocks cheaper now

Market News
02 Nov 2026, 23:29 WIB
Market Watch
View Source
Neutral
S&P 500 stagnant for 5 months but valuations drop, making stocks cheaper now

The S&P 500 index has barely moved in the past five months, closing almost exactly where it was at the end of May. Despite this stagnation, stock valuations have decreased significantly, with the forward price-to-earnings ratio falling below its five- and ten-year averages. This suggests that stocks may now be undervalued and could present buying opportunities for investors. Market volatility continues, but the overall market has quietly become more affordable.

The stock market's recent stagnation is presented here with Pluang's market data as of Nov 03, 2026 04:01 WIB. Among 150 priced US stocks tradable on Pluang, 60 rose and 89 fell today. Notable movers include BlackBerry Limited at USD 8.37 with a 1-day change of -8.92%, Intel Corp at USD 60.10 down 8.61%, and Rivian Automotive, Inc. at USD 13.17 up 8.31%.

More News

Global Indemnity delays Q3 earnings call to January, introducing new CEO Jessica Buss.

Global Indemnity delays Q3 earnings call to January, introducing new CEO Jessica Buss.

Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...

Market News
Neutral
55 minutes ago
Lorraine Ben joins Syntax Defence as Canada boosts defence spending over $500B in a decade

Lorraine Ben joins Syntax Defence as Canada boosts defence spending over $500B in a decade

Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...

Market News
Bullish
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
2 hours ago
Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
2 hours ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App